Related Experiment Video
Updated: Jul 19, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential
Jonathan D Smith1, Eric J Topol
1Cleveland Clinic Lerner College of Medicine, Department of Cell Biology, Cleveland Clinic, Cleveland, OH 44195, USA. smithj4@ccf.org
Abstract:
Atherosclerosis is a common, complex trait, with genetic variation in many genes and the environment contributing to risk for this condition, which has multiple and highly variable phenotypic manifestations. Progress has been made in the identification of atherosclerosis-modifying genes in both human studies and through the use of animal models. In the future, it may be possible to administer a genetic test for variation in a handful of the most common atherosclerosis-modifier genes, and thus predict if a patient is likely to develop atherosclerosis and ischemic heart disease. These patients could then be treated aggressively to lower their low-density lipoprotein cholesterol levels and other risk factors, including counseling to make adjustments in their lifestyle. This review will summarize the methods and results thus far in the identification of atherosclerosis-modifier genes.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu